Starfire Investment Advisers’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$37K Hold
177
0.02% 157
2020
Q1
$39K Hold
177
0.02% 146
2019
Q4
$47K Hold
177
0.02% 171
2019
Q3
$53K Hold
177
0.02% 171
2019
Q2
$58K Hold
177
0.03% 160
2019
Q1
$110K Hold
177
0.05% 156
2018
Q4
$43K Buy
+177
New +$70.4K 0.02% 141
2017
Q4
Sell
-120
Closed -$112K 204
2017
Q3
$112K Hold
120
0.07% 116
2017
Q2
$104K Hold
120
0.06% 122
2017
Q1
$82K Hold
120
0.04% 137
2016
Q4
$86.5K Hold
120
0.05% 136
2016
Q3
$88.4K Hold
120
0.05% 133
2016
Q2
$99.9K Buy
+120
New +$112K 0.07% 125

Other funds holding RMTI

Starfire Investment Advisers's RMTI Position: Q2 2020 in Review

Starfire Investment Advisers held its Rockwell Medical (RMTI) position steady in Q2 2020 at 177 shares worth $37K. The position accounts for 0.02% of the portfolio, ranked #157.

Starfire Investment Advisers first reported a position in RMTI in Q2 2016 and has held it in 13 quarters since. The position peaked at $112K in Q3 2017. 79 funds tracked by Wall St. Rank hold RMTI as of Q2 2020.

  • Starfire Investment Advisers held 177 shares of Rockwell Medical worth $37K as of Q2 2020.
  • Starfire Investment Advisers left its Rockwell Medical share count unchanged in Q2 2020.
  • Rockwell Medical made up 0.02% of Starfire Investment Advisers's portfolio in Q2 2020, its #157 holding.
  • Starfire Investment Advisers first reported a position in Rockwell Medical in Q2 2016 and has held it in 13 quarters since.
  • Starfire Investment Advisers's Rockwell Medical position peaked at $112K in Q3 2017.
  • 79 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.